NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

One thing is clear, blockbusters are not left in the hands of baby bios. Top 10 drugs from last year:

1) Keytruda. MRK acquired pre-clincial.
2) Comimaly, Pfizer - COVID
3) Humira, Abbvie - Acquired by Abbot early stage trials
4) Paxlovid, Pfizer - COVID
5) Elquis, Pfizer/BMS - pre-clinical
6) Opdivo BMS - pre-clinical
7) Dupexent, Sanifi - Regeneron - Sani partnered with Regeneron in phase 2 trials Arguably REGN was close to BP status by then.
8) Stelara, J&J - Purchased Centocore in 1999, several years prior to approval
9) Spikevax, Moderna - COVID
10) BKtarvy, Gillead.- Developed n house.

So, if BP wants a drug, they buy it.